Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
The PIONEER 5 study was a multicenter, double-blind, randomized, placebo-controlled, phase 3a trial where 324 participants, age 18yrs, with type 2 diabetes, HbA1C 7.0-9.0% and moderate renal impairment (eGFR 30-59 mL/min/1.732), were randomly assigned to receive either once-daily oral semaglutide on an empty stomach with up to half a glass of water and 30min before any food/beverage/medication, or placebo for 26 weeks with a follow up period of 5 weeks, with their standard glucose-lowering medication
If you take anticoagulants like warfarin, discuss ginger supplementation with your healthcare provider before starting
L-Carnitine supplementation in advanced pancreatic cancer (CARPAN)a randomized multicenter trial
These agents play a crucial role in managing blood glucose levels and improving glycemic control in individuals with diabetes
US$ 28.82
US$ 29.65
US$ 21.94
US$ 24.06
US$ 27.05
US$ 29.36
US$ 27.44
